Physician

Cyrus H. Nozad, M.D.

According to 2025 Medicare claims, Cyrus Nozad, M.D. (NPI: 1457528655) practices allergy/immunology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07012-1647. Nozad is affiliated with the WESTMED Medical Group (ACO ID: A1199) and Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Nozad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 156 traditional Medicare patients, billed 5,586 HCPCS/CPT codes, and received $87,260 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,028 prescription claims across 184 beneficiaries totaling $441,821 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 184 claims. Open Payments data shows 1 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $29,171 to $87,260. Similarly, Part D prescription costs have moved sharply higher in recent years, from $20,296 to $441,821. In contrast, DME billing represents a smaller volume and rose steadily, from $348 to $1,994.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	65	3,121	$29,171
2016	86	3,074	$35,222
2017	101	2,986	$45,170
2018	88	2,677	$34,266
2019	134	2,736	$33,510
2020	112	2,052	$28,489
2021	134	3,484	$54,087
2022	130	3,199	$52,367
2023	136	3,817	$60,155
2024	156	5,586	$87,260

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	225	$20,296
2016	66	284	$22,034
2017	77	381	$38,892
2018	76	364	$71,798
2019	105	442	$101,771
2020	116	495	$130,077
2021	124	567	$171,607
2022	147	715	$315,094
2023	157	868	$434,644
2024	184	1,028	$441,821

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$1,670
2019	N/R	N/R	N/R
2020	N/R	98	$254,687
2021	N/R	70	$261,585
2022	N/R	101	$323,670
2023	N/R	99	$362,716
2024	N/R	184	$406,698

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	31	31	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	49	$95
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	54	54	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	87	166	$69
95004	Test for allergy using allergenic extract	57	2,134	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	82	2,268	$310,470
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	1,680	$36,286
Breo Ellipta	Fluticasone/Vilanterol	22	780	$10,365
Xhance	Fluticasone Propionate	13	450	$8,789
Symbicort	Budesonide/Formoterol Fumarate	26	780	$5,584

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	51	$290,352
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	45	$103,963
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	32	$10,549
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	15	$1,153
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	28	$345

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$131	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cyrus H. Nozad, M.D.?

Tedicare shows public-source Medicare data for Cyrus H. Nozad, M.D. (NPI 1457528655), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cyrus H. Nozad, M.D. have ACO affiliation data?

Cyrus H. Nozad, M.D. is shown with ACO affiliation data for WESTMED Medical Group (MSSP, ACO ID A1199) and Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Cyrus H. Nozad, M.D.?

Cyrus H. Nozad, M.D. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Cyrus H. Nozad, M.D. have Open Payments data?

Cyrus H. Nozad, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.